Bulk Drug Intermediates – A Market Review

Bulk drug intermediates are the drugs used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry. Pharmaceutical companies use drugs intermediates for research and development purposes. Pharmaceutical intermediates, veterinary drug intermediates, and bulk drug intermediates are various types of drug intermediates. The global drug intermediate market is expected to grow at a high rate owing to rising research and development activity globally.

The market of drug intermediates is segmented on the basis of type of intermediate, end user, and by region. On the basis of type of intermediate, the market is segmented into two main types:

API intermediate: API or active pharmaceutical ingredient intermediates are the raw materials or raw drugs responsible for therapeutic action. They are the active ingredients which are later converted into various forms such as tablets, capsules, suspensions etc. API acts as a drug itself.

Advanced intermediate:Advanced intermediates are advanced forms of drug intermediates.
Advanced intermediate drugs are used to perform drug interaction activity which formed in new chemical products.

On the basis of end user, the global drug intermediate market is segmented into Pharmaceutical industry, Biotechnology industry, and Chemical industry.

Drug intermediates are available in various forms such as moderate quality intermediates, high quality intermediates, and premium quality intermediates. The high and premium quality drug intermediates are used mainly for research purposes. There has been an ever increasing global demand for quality drug intermediates due to the fast growing biotechnology and life sciences sectors, along with rising adoption and increasing application in research fields. Pharmaceutical companies and biotechnology companies, along with research companies are growing focus toward R&D in drug discovery and development.

By geography, the market for drug intermediates is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific leads the drug intermediate market owing to rising pharmaceutical and life sciences industry in the region especially in emerging markets in countries such as India and China. Europe is the second leading market for drug intermediates due to development and expansion of more efficient and advanced technologies. The Asia Pacific drug intermediate market is also anticipated to expand at an increasing rate owing to increasing healthcare spending, adoption of western lifestyle, and growth in research and development.

The rising competition in the pharmaceutical and biotechnology industry for outsourcing of drug intermediates and manufacturing of drug intermediates is expected to boost the growth of the global drug intermediate market.